SEC Form 4Coverage since Jul 31, 2026
$BSX insider trading
Over the last 12 months, Boston Scientific insiders reported 4 buys totaling $9.4M and no sales across SEC Form 4 filings.
- Bought · 12m
- $9.4M 4 events
- Sold · 12m
- — 0 events
- Events · 12m
- 4 Form 4 filings, grouped
- Insiders · 12m
- 3 distinct reporters
- 10b5-1 share
- 0% pre-arranged plans
Side
Price · $BSX · 12Mvia TradingView
Top insiders · 12m
Habiger David C—2× · $157K
Mahoney Michael FChairman, President & CEO1× · $9.0M
LUDWIG EDWARD J—1× · $227K
All insider trades
4 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | Habiger David CD | ▲ Buy | 2,100 | $47.59 | $100K | +13.9% | — |
| Aug 4, 2026 | Habiger David CD | ▲ Buy | 1,182 | $48.13 | $57K | +8.5% | 2 tranches |
| Aug 3, 2026 | Mahoney Michael FChairman, President & CEO · O·D | ▲ Buy | 186,240 | $48.33 | $9.0M | +13.3% | — |
| Jul 31, 2026 | LUDWIG EDWARD JD | ▲ Buy | 5,000 | $45.48 | $227K | +19.7% | — |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $BSX feed.